Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldesleukin + Rituximab in Follicular NHL
NCT00100737Phase 2Terminated
- Sponsor
- Chiron Corporation
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in follicular lymphoma (FL), sponsored by Chiron Corporation. Status: terminated.
02
Drugs
aldesleukin
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00100737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100737.